Eli Lilly And Stock Hits New 52-Week High (LLY)

NEW YORK ( TheStreet) -- Eli Lilly and Company (NYSE: LLY) hit a new 52-week high Friday as it is currently trading at $43.35, above its previous 52-week high of $43.31 with 599,490 shares traded as of 10:35 a.m. ET. Average volume has been six million shares over the past 30 days.

Eli Lilly and has a market cap of $49.67 billion and is part of the health care sector and drugs industry. Shares are up 3% year to date as of the close of trading on Thursday.

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company has a P/E ratio of 11.1, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Eli Lilly and as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Eli Lilly and Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

If you liked this article you might like

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Eli Lilly Still Looking for Lower Prices

Is Lilly Headed for the Valley?

Walmart, With Extra $10M Fund, Is Among 7 Giving for Hurricane Irma Relief